68 related articles for article (PubMed ID: 17784569)
1. [Endothelial dysfunction and renal lesion in obesity].
Mukhin NA; Fomin VV; Saginova EA; Moiseev SV; Kutyrina IM; Lebedeva MV; Minakova EG; Gitel' EP; Samokhodskaia LM; Domracheva TS
Vestn Ross Akad Med Nauk; 2006; (12):25-31. PubMed ID: 17784569
[TBL] [Abstract][Full Text] [Related]
2. Microalbuminuria and hypertension in HIV-infected patients: a preliminary study of telmisartan.
Ucciferri C; Falasca K; Mancino P; Di Iorio A; Vecchiet J
Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):491-8. PubMed ID: 22696876
[TBL] [Abstract][Full Text] [Related]
3. [Development of renal affection in obese patients].
Saginova EA; Fedorova EIu; Fomin VV; Moiseev SV; Minakova EG; Gitel' EP; Samokhodskaia LM; Kutyrina IM; Mukhin NA
Ter Arkh; 2006; 78(5):36-41. PubMed ID: 16889047
[TBL] [Abstract][Full Text] [Related]
4. Endothelial dysfunction: how can one intervene at the beginning of the cardiovascular continuum?
Schmieder RE
J Hypertens Suppl; 2006 Apr; 24(2):S31-5. PubMed ID: 16601559
[TBL] [Abstract][Full Text] [Related]
5. High FFA levels related to microalbuminuria and uncoupling of VEGF-NO axis in obese rats.
Sun X; Yu Y; Han L
Int Urol Nephrol; 2013 Aug; 45(4):1197-207. PubMed ID: 23563804
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial dysfunction tested by blunted response to endothelium-dependent vasodilation by salbutamol and its related factors in uncomplicated pre-menopausal obese women.
Suh HS; Park YW; Kang JH; Lee SH; Lee HS; Shim KW
Int J Obes (Lond); 2005 Feb; 29(2):217-22. PubMed ID: 15570314
[TBL] [Abstract][Full Text] [Related]
7. Is insulin-like growth factor 1 a determinant of renal haemodynamics in obesity hypertension?
Díez J; Ruilope LM; Rodicio JL
J Hypertens Suppl; 1993 Dec; 11(5):S192-3. PubMed ID: 8158338
[No Abstract] [Full Text] [Related]
8. Perirenal fat associated with microalbuminuria in obese rats.
Hou N; Han F; Wang M; Huang N; Zhao J; Liu X; Sun X
Int Urol Nephrol; 2014 Apr; 46(4):839-45. PubMed ID: 24526332
[TBL] [Abstract][Full Text] [Related]
9. The effect of flutamide on systemic and renal hemodynamics in Zucker diabetic rats: paradoxic renal vasodilator response to endothelin-1 and TXA2 receptor activation in female sex.
Ajayi AA; Fidelis P
J Cardiovasc Pharmacol; 2006 Nov; 48(5):191-8. PubMed ID: 17110800
[TBL] [Abstract][Full Text] [Related]
10. Changes in insulin sensitivity, renal function, and markers of endothelial dysfunction in hypertension--the impact of microalbuminuria: a 13-year follow-up study.
Solbu MD; Jenssen TG; Eriksen BO; Toft I
Metabolism; 2009 Mar; 58(3):408-15. PubMed ID: 19217459
[TBL] [Abstract][Full Text] [Related]
11. Microalbuminuria, endothelial dysfunction and inflammation in primary hypertension.
Perticone F; Maio R; Tripepi G; Sciacqua A; Mallamaci F; Zoccali C
J Nephrol; 2007; 20 Suppl 12():S56-62. PubMed ID: 18050145
[TBL] [Abstract][Full Text] [Related]
12. Lack of association between endothelial nitric oxide synthase gene polymorphisms, microalbuminuria and endothelial dysfunction in hypertensive men.
Dell'Omo G; Penno G; Pucci L; Fotino C; Lucchesi D; Del Prato S; Pedrinelli R
J Hypertens; 2007 Jul; 25(7):1389-95. PubMed ID: 17563560
[TBL] [Abstract][Full Text] [Related]
13. [The importance of the endothelium in heart failure].
Leite-Moreira AF; Cerqueira-Gomes M
Rev Port Cardiol; 1997 Apr; 16(4):399-406, 353. PubMed ID: 9254129
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of normotensive renal transplant recipients with microalbuminuria and effects of angiotensin II type I receptor antagonist on urinary albumin excretion.
Satoh S; Horikawa Y; Kakinuma H; Tsuchiya N; Wang L; Kato T; Habuchi T
Int J Urol; 2004 Aug; 11(8):585-91. PubMed ID: 15285746
[TBL] [Abstract][Full Text] [Related]
15. Residual proteinuria and eGFR predict progression of renal impairment within 2 years in type 2 diabetic patients with nephropathy who are receiving optimal treatment with angiotensin receptor blockers.
Ivory SE; Packham DK; Reutens AT; Wolfe R; Rohde RD; Lewis J; Atkins RC;
Nephrology (Carlton); 2013 Jul; 18(7):516-24. PubMed ID: 23506627
[TBL] [Abstract][Full Text] [Related]
16. A pilot study of the effect of atorvastatin on endothelial function and albuminuria in sickle cell disease.
Ataga KI; Wichlan D; Elsherif L; Derebail VK; Wogu AF; Maitra P; Cai J; Caughey MC; Pollock DM; Pollock JS; Archer DR; Hinderliter AL
Am J Hematol; 2019 Nov; 94(11):E299-E301. PubMed ID: 31407373
[No Abstract] [Full Text] [Related]
17. Microalbuminuria as a risk factor: the influence of renin-angiotensin system blockade.
Menne J; Chatzikyrkou C; Haller H
J Hypertens; 2010 Oct; 28(10):1983-94. PubMed ID: 20634721
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and factors associated with microalbuminuria and abnormal renal function in Thai obese adults.
Eiamthanasinchai S; Laowahutanont N; Yamwong P; Teerapornlertratt T
J Med Assoc Thai; 2013 Feb; 96 Suppl 2():S9-16. PubMed ID: 23590016
[TBL] [Abstract][Full Text] [Related]
19. Endothelial vasomotor dysfunction in the brachial artery predicts the short-term development of early stage renal dysfunction in patients with coronary artery disease.
Nakamura T; Obata JE; Hirano M; Kitta Y; Sano K; Kobayashi T; Fujioka D; Saito Y; Yano T; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
Int J Cardiol; 2011 Apr; 148(2):183-8. PubMed ID: 19945185
[TBL] [Abstract][Full Text] [Related]
20. Selective endothelin ETA and dual ET(A)/ET(B) receptor blockade improve endothelium-dependent vasodilatation in patients with type 2 diabetes and coronary artery disease.
Rafnsson A; Shemyakin A; Pernow J
Life Sci; 2014 Nov; 118(2):435-9. PubMed ID: 24607773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
